Silgan Holdings

SLGN

Market cap $4.44B

German medical packaging maker Gerresheimer has rejected ​a takeover bid from its ‌U.S. rival Silgan , three sources familiar with the situation told ​Reuters.

Investors need to pay close attention to SLGN stock based on the movements in the options market lately.

NORWALK, Conn.--(BUSINESS WIRE)--Silgan to Release First Quarter 2026 Earnings Results on April 29, 2026.

Silgan Holdings delivered robust 2025 results, with revenue up over 10% and EBIT rising 15% to nearly $600 million, driven by the Weener Plastics acquisition. SLGN generated about $400 million in free cash flow, comfortably covering its dividend and supporting rapid net debt reduction, despite net debt standing at 3.5x EBITDA. Guidance for 2026 targets $450 million in free cash flow and adjusted EPS of $3.7–$3.9, with a $500 million buyback program activated but not yet utilized.

U.S. packaging company Silgan Holdings has signalled interest in taking over German ​medical packaging maker Gerresheimer GXIG.DE, according to ‌two sources familiar with the matter.

Silgan (SLGN) reported earnings 30 days ago. What's next for the stock?

NORWALK, Conn.--(BUSINESS WIRE)--SILGAN INCREASES DIVIDEND FOR 22nd CONSECUTIVE YEAR SINCE INITIATION AND DECLARES QUARTERLY DIVIDEND.

Silgan Holdings Inc. (SLGN) Q4 2025 Earnings Call Transcript

Although the revenue and EPS for Silgan (SLGN) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Silgan Holdings (SLGN) came out with quarterly earnings of $0.67 per share, beating the Zacks Consensus Estimate of $0.65 per share. This compares to earnings of $0.85 per share a year ago.